Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Elicio Therapeutics, Inc.
vedantra.comAI Executive Summary
AI-powered analysis of 8-K filing content
Elicio Therapeutics secured a $100 million At-the-Market (ATM) offering agreement with three sales agents, allowing the company to issue common stock flexibly based on market conditions to fund immunotherapy development.
Key Takeaways
Company entered into an ATM agreement with B. Riley Securities, JonesTrading Institutional Services, and Ladenburg Thalmann & Co. for up to $100 million in common stock sales
The offering provides capital flexibility, allowing Elicio to raise funds opportunistically aligned with market conditions rather than in a single transaction
2 more takeaways
Related Filings (1)
1 more filing from Elicio Therapeutics, Inc. in the last 90 days